These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36479797)

  • 1. Nanostructured Heterogeneous Catalysts for Bioorthogonal Reactions.
    Sousa-Castillo A; Mariño-López A; Puértolas B; Correa-Duarte MA
    Angew Chem Int Ed Engl; 2023 Mar; 62(10):e202215427. PubMed ID: 36479797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition Metal Ru(II) Catalysts Immobilized Nanoreactors for Conditional Bioorthogonal Catalysis in Cells.
    Gao Z; Li Y; Xing J; Lu Y; Shao Q; Hu J; Zhao S; He W; Sun B
    ACS Appl Mater Interfaces; 2024 Apr; 16(13):15870-15878. PubMed ID: 38520329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From mechanism to mouse: a tale of two bioorthogonal reactions.
    Sletten EM; Bertozzi CR
    Acc Chem Res; 2011 Sep; 44(9):666-76. PubMed ID: 21838330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ activation of therapeutics through bioorthogonal catalysis.
    Wang W; Zhang X; Huang R; Hirschbiegel CM; Wang H; Ding Y; Rotello VM
    Adv Drug Deliv Rev; 2021 Sep; 176():113893. PubMed ID: 34333074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designer Nanoreactors for Bioorthogonal Catalysis.
    Kumar A; Lee IS
    Acc Chem Res; 2024 Feb; 57(3):413-427. PubMed ID: 38243820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioorthogonal Decaging Reactions for Targeted Drug Activation.
    Davies S; Stenton BJ; Bernardes GJL
    Chimia (Aarau); 2018 Nov; 72(11):771-776. PubMed ID: 30514419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards bioorthogonal catalysis with organometallic compounds.
    Völker T; Dempwolff F; Graumann PL; Meggers E
    Angew Chem Int Ed Engl; 2014 Sep; 53(39):10536-40. PubMed ID: 25138780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioorthogonal chemistry: strategies and recent developments.
    Ramil CP; Lin Q
    Chem Commun (Camb); 2013 Dec; 49(94):11007-22. PubMed ID: 24145483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-Specific Bioorthogonal Reactions for Precise Biomedical Applications.
    Liu Z; Sun M; Zhang W; Ren J; Qu X
    Angew Chem Int Ed Engl; 2023 Dec; 62(49):e202308396. PubMed ID: 37548083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomaterial-based bioorthogonal nanozymes for biological applications.
    Fedeli S; Im J; Gopalakrishnan S; Elia JL; Gupta A; Kim D; Rotello VM
    Chem Soc Rev; 2021 Dec; 50(24):13467-13480. PubMed ID: 34787131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in controllable bioorthogonal catalysis for prodrug activation.
    Liu X; Huang T; Chen Z; Yang H
    Chem Commun (Camb); 2023 Oct; 59(84):12548-12559. PubMed ID: 37791560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells.
    Wang F; Zhang Y; Du Z; Ren J; Qu X
    Nat Commun; 2018 Mar; 9(1):1209. PubMed ID: 29572444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational Utilization of Black Phosphorus Nanosheets to Enhance Palladium-Mediated Bioorthogonal Catalytic Activity for Activation of Therapeutics.
    Rong M; Liu J; Sun Z; Li T; Li Y; Jiang C; Lu L
    Angew Chem Int Ed Engl; 2023 May; 62(19):e202216822. PubMed ID: 36917027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inorganic nanoparticles as scaffolds for bioorthogonal catalysts.
    Hirschbiegel CM; Zhang X; Huang R; Cicek YA; Fedeli S; Rotello VM
    Adv Drug Deliv Rev; 2023 Apr; 195():114730. PubMed ID: 36791809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal-free bioorthogonal click chemistry in cancer theranostics.
    Wu D; Yang K; Zhang Z; Feng Y; Rao L; Chen X; Yu G
    Chem Soc Rev; 2022 Feb; 51(4):1336-1376. PubMed ID: 35050284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Motor-Based Carbonaceous Nanocalabash Catalyst for Deep-Layered Bioorthogonal Chemistry.
    Liu C; Niu J; Cui T; Ren J; Qu X
    J Am Chem Soc; 2022 Oct; 144(42):19611-19618. PubMed ID: 36240426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bioorthogonal nanosystem for imaging and in vivo tumor inhibition.
    Li B; Liu P; Wu H; Xie X; Chen Z; Zeng F; Wu S
    Biomaterials; 2017 Sep; 138():57-68. PubMed ID: 28554008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.
    Weiss JT; Dawson JC; Fraser C; Rybski W; Torres-Sánchez C; Bradley M; Patton EE; Carragher NO; Unciti-Broceta A
    J Med Chem; 2014 Jun; 57(12):5395-404. PubMed ID: 24867590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioorthogonal catalytic nanozyme-mediated lysosomal membrane leakage for targeted drug delivery.
    Sun Z; Liu Q; Wang X; Wu J; Hu X; Liu M; Zhang X; Wei Y; Liu Z; Liu H; Chen R; Wang F; Midgley AC; Li A; Yan X; Wang Y; Zhuang J; Huang X
    Theranostics; 2022; 12(3):1132-1147. PubMed ID: 35154478
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioorthogonal strategies for the in vivo synthesis or release of drugs.
    Lozhkin B; Ward TR
    Bioorg Med Chem; 2021 Sep; 45():116310. PubMed ID: 34365101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.